IREN
NASDAQ · IRENInvestableEntry review due
$38.69
Oct 7, 2026-6.27%last session
Close
Oct 7, 2026
Entry rationale
At the dated reference price, I would wait for evidence that commissioned AI capacity is becoming recognized revenue without construction spending and financing needs overwhelming the shareholder outcome. The concern is execution and funding, not losses alone.